H.E.L Group has announced the appointment of Oh Chee Keat (Brice Oh) as Regional Sales Director for Asia-Pacific.

CN Bio has announced that the U.S. Food and Drug Administration (FDA) has extended their research collaboration for a further three years.

Sygnature Discovery has established a new office presence in South San Francisco’s biotech hub at Oyster Point, where it can better serve current and future clients on the US west coast.

GenNext Technologies, Inc., has announced that nearly $7M in NIH grant awards has led to a seminal US patent for its novel technology that vastly improves the utility of protein footprinting for the study of biopharmaceutical higher-order structure.

Turbine has announced that it has appointed Dr. Mark Velleca as Chair of the Board of Directors. The company also announced that Professor Gordon Mills and Dr. Klaus Hoeflich have joined its Scientific Advisory Board (SAB).

Aigenpulse has rolled out an update to its CytoML Experiment Suite – which includes new unbiased analysis features and has an easy-to-use interface with no need for difficult installation or program scripting.

Tosoh Bioscience LLC has announced the introduction of its TSKgel FcR-IIIA-5PW HPLC column.

ERS Genomics Limited and NUVISAN Innovation Campus Berlin (ICB) GmbH have announced a non-exclusive license agreement granting NUVISAN ICB access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

Metrion Biosciences Limited has announced the appointment of Mark Keogh as a Non-Executive Director.

Phico Therapeutics Ltd has been awarded a grant of up to $18.2 million USD from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). The funding will support the progression of Phico’s lead product SASPject™ PT3.9 through clinical trials.